Chargement de la fiche…
rhumatologie
Pr Christophe Richez
Hospitalo-universitaire
Bordeaux (33076)
Systemic Lupus Erythematosus Research · Rheumatoid Arthritis Research and Therapies · Spondyloarthritis Studies and Treatments
0Publications
0Citations
0Thèses dirigées
0Vidéos
0Citations de la publi la +
EnseignementExpérience confirmée
Après la consultation, le Pr Christophe Richez peut vous remettre une sélection de ressources adaptée à votre pathologie. Vous avez reçu un code ? Saisissez-le →
Ce qu'il est utile d'apporter à votre rendez-vous avec le Pr Christophe Richez. Cochez au fur et à mesure — la liste vous suit sur toutes les fiches.
Documents / notes
Examens à apporter
Traitement
Pourquoi consulter Pr Christophe Richez
- Plateau technique de référence
- Auteur de référence en rhumatologie
- Encadrant universitaire
- Conseils vidéo gratuits
- Référence presse grand public
- Expérience confirmée
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Parcours
2010–2026
Centre National de la Recherche Scientifique
2024
Lyon 1 Université
2023
Sciences Po Bordeaux
2023
University of Lisbon
2019
Hofstra University
2017
Université Paris-Sud
Rayonnement scientifique
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 51 articles cités au moins 51fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Dernières publications
Publications les plus citées
51 citationsCAR T-cell therapy in autoimmune diseases: where are we and where are we going?2025 · The Lancet. RheumatologyPubMed ↗48 citationsSafety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme2023 · Annals of the rheumatic diseasesPubMed ↗22 citationsBaricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial2025 · The Lancet. RheumatologyPubMed ↗
Diplômes & qualifications
DES
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieu d'exercice
Domaines d'expertise
Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders ResearchSystemic Sclerosis and Related Diseases
Bibliométrie (OpenAlex)
Profil ↗0
travaux
0
h-index
0
i10-index
0
citations
Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders ResearchSystemic Sclerosis and Related Diseases
Transversal
252026Joint bone spine
PubMed ↗Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
2026Joint bone spine
PubMed ↗Answer to Elbaz et al
2026RMD open
PubMed ↗Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
2026Annals of the rheumatic diseases
PubMed ↗Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched study
2026La Revue de medecine interne
PubMed ↗[Sustainable healthcare transition: A guide for deprescribing unnecessary biological tests]
2026BMC women's health
PubMed ↗Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study
2026Joint bone spine
PubMed ↗Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseases
2025La Revue de medecine interne
PubMed ↗French protocol for the diagnosis and management of giant cell arteritis
2025The Lancet. Rheumatology
PubMed ↗CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2025RMD open
PubMed ↗Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
2025La Revue de medecine interne
PubMed ↗Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
2025Lupus science & medicine
PubMed ↗Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluated
2025Joint bone spine
PubMed ↗Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study
2025The European respiratory journal
PubMed ↗Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease
2025BMC rheumatology
PubMed ↗Disease activity during pregnancy in patients with rheumatoid arthritis or spondyloarthritis: results from the multicentre prospective GR2 study
2024Clinical and experimental rheumatology
PubMed ↗Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Seminars in arthritis and rheumatism
PubMed ↗Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study
2024Joint bone spine
PubMed ↗2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
2024RMD open
PubMed ↗Concordance and agreement between different activity scores in polymyalgia rheumatica
2024Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
PubMed ↗Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
2024Nature communications
PubMed ↗Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiology
2023RMD open
PubMed ↗Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
2023Scientific reports
PubMed ↗Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment
2023Joint bone spine
PubMed ↗Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort
2023Joint bone spine
PubMed ↗Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
Lupus
92026EBioMedicine
PubMed ↗Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases
2025Expert review of clinical pharmacology
PubMed ↗Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus
2025The Lancet. Rheumatology
PubMed ↗ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
2025BJOG : an international journal of obstetrics and gynaecology
PubMed ↗Safety of Fertility Treatments in Women With Systemic Lupus Erythematosus: Data From a Prospective Population-Based Study
2025Rheumatology (Oxford, England)
PubMed ↗Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
2024La Revue de medecine interne
PubMed ↗French protocol for the diagnosis and management of systemic lupus erythematosus
2024Arthritis care & research
PubMed ↗Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
2024Expert review of clinical immunology
PubMed ↗Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus
2024Journal of clinical medicine
PubMed ↗No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
Épidémiologie & registres
52026BMC rheumatology
PubMed ↗Prevalence of effective contraceptive use among patients with rheumatic diseases: a descriptive study
2024Rheumatology (Oxford, England)
PubMed ↗Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases
2024Rheumatology (Oxford, England)
PubMed ↗Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry
2024The Journal of infection
PubMed ↗Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
2024Arthritis care & research
PubMed ↗Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
JAK inhibiteurs
32025ACR open rheumatology
PubMed ↗Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis
2025The Lancet. Rheumatology
PubMed ↗Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
2023Annals of the rheumatic diseases
PubMed ↗Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Pharmacovigilance
32025Drug safety
PubMed ↗Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
2025Drug safety
PubMed ↗Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
2025Drug safety
PubMed ↗Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
Biothérapies non-anti-TNF
22025BMJ open
PubMed ↗Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
csDMARDs
22025The Lancet. Rheumatology
PubMed ↗Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025Rheumatology (Oxford, England)
PubMed ↗Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients
AINS
12024RMD open
PubMed ↗NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort
Corticothérapie
12025Annals of the rheumatic diseases
PubMed ↗Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Essai clinique
12025Annals of the rheumatic diseases
PubMed ↗Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Génétique
12024RMD open
PubMed ↗Anifrolumab: the new frontier in the treatment of genetic interferonopathies
Risque cardio-vasculaire
12023Annals of the rheumatic diseases
PubMed ↗Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Publications HAL
82026Article
Answer to Elbaz et al.
Joint Bone Spine
2026Article
Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis
Journal of the European Academy of Dermatology and Venereology
2026Article
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study
RMD Open
2026Article
Soluble CD95L triggers Caspase-10-driven reactive oxygen species production in neutrophils and aggravates anti-neutrophil cytoplasmic antibody-vasculitis
Nature Communications
2026Article
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
RMD Open
2026Article
Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study
BMC Women's Health
2026Article
Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases
EBioMedicine
2026Article
Prevalence of effective contraceptive use among patients with rheumatic diseases: a descriptive study
BMC Rheumatology
Vidéos
5
▶Christophe RICHEZ - Présentation et actualités CRMR
RESO Bordeaux
▶Lupus érythémateux systémique Diagnostic 12'12Pr Christophe Richez
mohamed mammeri
▶01 Présentation CRMR, CCMR et actualités
RESO Bordeaux
▶Recherche : Qu'est-ce que le protocole CRI-RA ?
Polyarthrite Andar
▶Vidéo N°1 : Qu'est-ce qu'un médicaments biologique ou une biothérapie ?
Association France Spondyloarthrites AFS
Direction de thèses
2Encadrement de doctorants — signal d'activité universitaire.
2020Doctorant : Marc Scherlinger
Les sélectines inhibent la fonction des lymphocytes T régulateurs et contribuent à la pathogénie du lupus érythémateux systémique
Bordeaux
2014Doctorant : Liliane Khoryati
Propriétés immuno-modulatrices des IgE dans le lupus érythémateux systémique : impact sur la sécrétion d’interféron de type I par les cellules dendritiques plasmacytoïdes
Bordeaux
Rhumatologues à proximité
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.